Where does New York Blood Center, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), New York Blood Center, Inc. ranks #8,084 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does New York Blood Center, Inc. hold?

New York Blood Center, Inc. holds 40 US utility patents granted between 2015 and 2025, spanning 18 technology areas.

What is New York Blood Center, Inc.'s Innovation Score?

New York Blood Center, Inc. has an Innovation Score of 43.1 out of 100 (top 29% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does New York Blood Center, Inc. focus on?

New York Blood Center, Inc.'s top technology area is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes) with 31 patents, ranking #730 of 7,163 assignees active in that subclass. Grants appear in 18 CPC subclasses total.

Is New York Blood Center, Inc.'s patent grant rate increasing or decreasing?

New York Blood Center, Inc.'s recent grant velocity is -39% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for New York Blood Center, Inc.'s patents?

New York Blood Center, Inc.'s patents average 14.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the New York Blood Center, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

New York Blood Center, Inc.

USPTO PatentsView assignee record - 40 granted patents across 18 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, New ranks #8,084 of 49,997 tracked US assignees by granted-patent volume, with 40 patents across 18 technology areas.

#8,084
of 49,997 US assignees by volume: Top 29%
by Innovation Score (43.1/100): 14.3
avg claims per patent: -39%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R8084 · US Corporation #8,084 · 40 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-DOWN · BOOK-FULL

GRANTS-SMALL 40 grants
UPPER-Q #8,084/49,997
PHOTO-FINISH National Oilwell…
CPC-FOCUS A61K · 18 areas
INNOV-PAR 43.1/100
CLAIMS-RICH 14.3 claims/avg
TYPE-USCORP US Corporation
VEL-DOWN -39% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: National Oilwell Varco Denmark I/S (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How New’s 43.1 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 12.8 pts (30%) Velocity 6.7 pts (16%) Breadth 15.0 pts (35%) Claim depth 8.6 pts (20%)

Qualcomm Incorporated · highest

85
AIC Innovations Group · near

43
Cascade · near

43
Mapbox · near

43
New York Blood Center · this assignee

43
ST Jude Medical… · near

43
3D Lighting… · lowest

7

What this shows New's Innovation Score is 43.1/100 (top 29% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for New?

Each dot is one of New’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). New’s own 14.3 claims/patent is at or below the 18.3 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

New vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where New's grants concentrate

New York Blood Center, Inc. is a focused PatentsView assignee: 18 CPC subclasses with 77.5% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2015 (8 grants) versus a trough of 1 in 2022. By volume, New sits between NEC (China) Co., Ltd. and Otsuka Electronics Co., Ltd..

New's three-year grant acceleration

New York Blood Center, Inc. shows 8 grants in 2022–2024 against only 8 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

NEC (China)

40
Norwegian Univers…

40
National Oilwell…

40
Neophotonics

40
Numerex

40
Oceus Networks

40
OMG

40
Otsuka

40
New York Blood Ce… ◀

40

What this shows New holds 40 patents at rank #8,083, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near New

By rank, the assignees closest to #8,083 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in New's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for New, neither rank-band nor same-CPC leaders (those blocks stay above). In A61K (Preparations FOR Medical), New ranks #730 of 7,163 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (43 here).

ST. Jude Medical Coordination Center Bvba 43 Cascade Corporation 43 AIC Innovations Group, Inc. 43 Mapbox, Inc. 43

New's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

43 Top 29% higher than 71% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

New York Blood Center, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	8	20.0%
2016	4	10.0%
2017	5	12.5%
2018	4	10.0%
2019	2	5.0%
2020	3	7.5%
2021	3	7.5%
2022	1	2.5%
2023	4	10.0%
2024	3	7.5%
2025partial year	3	7.5%

Which technologies does New York Blood Center, Inc. patent most?

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 31

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 23

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 22

C07K - Peptides 17

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 7

C07D - Heterocyclic Compounds 7

A01N - Preservation OF Bodies OF Humans OR Animals OR Plants OR Parts Thereof ; Biocides, e.g. AS Disinfectants, AS Pesticides OR AS Herbicides ; Pest Repellants OR ATTRACTANTS; Plant Growth Regulators 6

A01K - Animal HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; Rearing OR Breeding Animals, NOT Otherwise Provided FOR; NEW Breeds OF Animals 6

C07C - Acyclic OR Carbocyclic Compounds 6

Y02A - Technologies FOR Adaptation TO Climate Change 6

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 5

G06F - Electric Digital Data Processing 3

H04L - Transmission OF Digital Information, e.g. Telegraphic Communication 3

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 3

C12M - Apparatus FOR Enzymology OR MICROBIOLOGY; Apparatus FOR Culturing Microorganisms FOR Producing Biomass, FOR Growing Cells OR FOR Obtaining Fermentation OR Metabolic Products, i.e. Bioreactors OR Fermenters 2

Top 15 of 18 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

New York Blood Center, Inc.'s patent record in context - here's where to go next.

New York Blood Center, Inc.'s lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 77.5% of its portfolio - see every assignee active in that class. Explore A61K
Ranked #8,084 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare New York Blood Center, Inc. against NEC (China) Co., Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 43.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.